Monday, October 5, 2026
Biotech

Ennis Sales Rise as Profits Dip

Ennis shows strong sales growth, but lower earnings per share raise questions about the company's financial health.

Ennis Inc. just shared its latest financial numbers. The company makes business forms and products. It announced higher sales, which is good news for the business.

Sales grew by 6.6%. This means Ennis sold more products than before. However, the company also reported lower earnings per share. This number tells investors how much profit the company made for each share of stock.

Legal matters may be part of the reason for lower earnings. Ennis recorded a cost of $2.4 million for legal items. This money went towards fees and other expenses.

Even with lower earnings, Ennis still earned a profit. The company earned $0.29 per share. This is less than last year but still a positive number.

Investors will watch to see if Ennis can keep growing sales while also boosting its profits. The company's ability to manage costs, especially legal ones, will be key.

Source: Yahoo Finance

#Biotech

More from Biotech